{
    "Company Name": "Anthem Biosciences IPO",
    "IPO_Date": "July 14, 2025 to July 16, 2025",
    "Listing_Date": "[.]",
    "Face_Value": "2 per share",
    "Issue_Price_Band": "540 to 570 per share",
    "Lot_Size": "26 Shares",
    "Sale_Type": "Offer For Sale",
    "Total_Issue_Size": "5,95,61,404 shares (aggregating up to 3,395.00 Cr)",
    "Employee_Discount": "50.00 ",
    "Issue_Type": "Bookbuilding IPO",
    "Listing_At": "BSE, NSE",
    "Share_Holding_Pre_Issue": "76.87%",
    "Share_Holding_Post_Issue": "74.68%",
    "QIB_Shares_Offered": "Not more than 50.00% of the Net Issue",
    "Retail_Shares_Offered": "Not less than 35.00% of the Net Issue",
    "NII_Shares_Offered": "Not less than 15.00% of the Net Issue",
    "IPO_Open_Date": "Mon, Jul 14, 2025",
    "IPO_Close_Date": "Wed, Jul 16, 2025",
    "Tentative_Allotment": "Thu, Jul 17, 2025",
    "Initiation_of_Refunds": "Fri, Jul 18, 2025",
    "Credit_of_Shares_to_Demat": "Fri, Jul 18, 2025",
    "Tentative_Listing_Date": "Mon, Jul 21, 2025",
    "Cut-off_time_for_UPI_mandate_confirmation": "5 PM on July 16, 2025",
    "Retail_(Min)": "14,820",
    "Retail_(Max)": "1,92,660",
    "S-HNI_(Min)": "2,07,480",
    "S-HNI_(Max)": "9,92,940",
    "B-HNI_(Min)": "10,07,760",
    "ROE": "20.82%",
    "ROCE": "26.88%",
    "Debt/Equity": "0.05",
    "RoNW": "20.82%",
    "PAT_Margin": "23.38%",
    "EBITDA_Margin": "36.81%",
    "Price_to_Book_Value": "13.23",
    "EPS_(Rs)": "8.07",
    "P/E_(x)": "70.62",
    "Brokers": "0",
    "Members": "0"
}